Financhill
Back

Monopar Therapeutics Vs. Xtant Medical Holdings Industry Stock Comparison

Sell
39

MNPR
Monopar Therapeutics

Last Price:
0.61
Seasonality Move:
-11.47%
Sell
48

XTNT
Xtant Medical Holdings

Last Price:
0.73
Seasonality Move:
6.74%
Sell
39
Monopar Therapeutics (MNPR) is a Sell

Is Monopar Therapeutics a Buy, Sell or Hold?

  • The current Monopar Therapeutics [MNPR] share price is $0.61. The Score for MNPR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Xtant Medical Holdings (XTNT) is a Sell

Is Xtant Medical Holdings a Buy, Sell or Hold?

  • The current Xtant Medical Holdings [XTNT] share price is $0.72. The Score for XTNT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • XTNT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MNPR Stock Price Chart

What is Monopar Therapeutics's stock price today?

  • The Monopar Therapeutics share price today is $0.61
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight selling pressure.

XTNT Stock Price Chart

What is Xtant Medical Holdings's stock price today?

  • The Xtant Medical Holdings share price today is $0.72
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XTNT is experiencing slight selling pressure.

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 41.64 Sell
Chaikin Money Flow: -12021 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.62 - 0.72) Sell
Bollinger Bands (100): (0.39 - 0.83) Sell

XTNT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 33.3 Sell
Chaikin Money Flow: -19144 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.78 - 0.9) Sell
Bollinger Bands (100): (0.89 - 1.15) Sell

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.66 Sell
20-day SMA: 0.67 Sell
50-day SMA: 0.69 Sell
200-day SMA: 0.56 Buy
8-day EMA: 0.65 Sell
20-day EMA: 0.67 Sell
50-day EMA: 0.67 Sell
200-day EMA: 0.74 Sell

XTNT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.78 Sell
20-day SMA: 0.84 Sell
50-day SMA: 0.94 Sell
200-day SMA: 1.1 Sell
8-day EMA: 0.77 Sell
20-day EMA: 0.83 Sell
50-day EMA: 0.91 Sell
200-day EMA: 1 Sell

Monopar Therapeutics Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.01 per share, an increase this year of $0.31 per share, and an increase next year of $0.02 per share.

Xtant Medical Holdings Earnings Growth & XTNT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.01 per share, and an increase next year of $0.07 per share.

Monopar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Xtant Medical Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):